Aldeyra Therapeutics (ALDX) Other Non Operating Income (2013)
Aldeyra Therapeutics (ALDX) posted Other Non Operating Income of $9.9 million for Q4 2013, down 5.46% on a QoQ basis from $10.5 million in Q3 2013.
Aldeyra Therapeutics (ALDX) Other Non Operating Income (2013) Analysis & Trends
Aldeyra Therapeutics' Other Non Operating Income history runs 1 years deep, the most recent figure standing at $9.9 million for Q4 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,192.35 Bn | 67,192.06 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - |
| 4 | BeOne Medicines | 471.52 Bn | 466.73 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.73 Bn | 114.48 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.88 Bn | 61.13 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.11 Bn | 63.11 Bn | - |
| 8 | Argenx Se | 55.88 Bn | 50.70 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.48 Bn | 37.48 Bn | - |
| 10 | Aldeyra Therapeutics | 95.30 Mn | 95.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | 9.92 Mn |
| Sep 30, 2013 | 10.49 Mn |